Seminar/Event Detail

Novel Roles of Intragenic DNA Methylation in Transcription and Pre-mRNA Splicing

Date/Time: 08 March 2012, 1pm - 2pm
Speaker: Alika Maunakea, Ph.D.
Speaker Affiliation: National Heart, Lung & Blood Institute, National Institutes of Health in Bethesda, Maryland
Venue: MEB 314 (Auditorium), JABSOM
For more info:

Description: Alika K. Maunakea is the great-grandson of the late Kupuna Katherine Maunakea of the Waianae coast who introduced him to traditional Hawaiian medicine. Inspired by his Kupuna, Alika studied molecular and cell biology to investigate the pharmacological value of Hawaiian medicinal plants at Kamehameha Schools. After graduating in 1997, Alika went on to receive his bachelor’s degree in Biology at Creighton University and Ph.D. in Biomedical Sciences at the University of California, San Francisco. Currently, he is a post-doctoral research fellow at the National Institutes of Health in Bethesda, Maryland working with Dr. Keji Zhao in the fi eld of epigenetics within the National Heart, Lung & Blood Institute.

In mammals, DNA methylation is essential to embryonic development, differentiation, cell cycle control, and maintenance of genome stability. At promoters, methylation generally precludes transcription by blocking the binding of transcriptional activators directly or indirectly through the recruitment of methylbinding proteins and co-repressor complexes containing histone deacetylases that cooperatively facilitates the formation of heterochromatin. However, recent genome-wide studies have revealed that DNA methylation within gene bodies is far more frequent than at promoters. Such intragenic methylation is evolutionarily conserved, implying that it has a common ancestral function. Using high-throughput methodologies coupled with in-depth investigation of specific loci, we have found that intragenic DNA methylation regulates alternate promoter activity in vitro and in vivo, offering a mechanism for the expression of alternate transcripts in a tissue and cell type-specific manner. In addition, preferential positioning of DNA methylation over exons compared with introns prompted speculation for its potential role in pre-mRNA splicing, which remains largely unsubstantiated. We found that intragenic DNA methylation operates in exon definition to modulate pre-mRNA splicing and can enhance exon recognition via recruitment of the methyl-binding protein MeCP2. Together, these studies provide novel insight into the functional roles of intragenic DNA methylation in transcription and pre-mRNA splicing with important implications to disease.

Additional Document:Click here to download

15 September 2017:
RCMI Conference Travel Support

We are currently encouraging scientists engaged in health disparities research, healthcare and public health professionals, public policy professional…

10 September 2017:
Call for Abstracts: RCMI Translational Science 2017 Conference

Call for Abstracts

Abstract Deadline Extended

Submit Your Abstracts

Abstract submission for oral and poster presentations is…

16 May 2017:
Robert Wood Johnson Funding Opportunity

If our nation is to make the opportunity for health available to all, we need leaders who will be able to meet the challenges before us – leade…

View more news...

Seminars & Events
16 June 2017, 9am - 10:30am:
02 June 2017, 8:15am - 4:10pm:
02 November 2016, 9am:
RMATRIX-II Collaboration Pilot Projects Program 2017 -- Informational Webinar

View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.